Bastien Mangeat

Bastien Mangeat

Auto-generated profile, based on publicly available information

Bastien Mangeat

EPFL SV PTECH PTEG 2 , SV 1535 (Bâtiment SV), Station 19, CH-1015 Lausanne , Switzerland

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 May 2003 in Nature
Verified
Journal Article
Closed access
PDF file
BMBastien Mangeat
Bastien Mangeat
PTPriscilla Turelli
Priscilla Turelli
GCGersende Caron
Gersende Caron
MFMarc Friedli
Marc Friedli
LPLuc Perrin
Luc Perrin
DTDidier Trono
Didier Trono

2 August 2023 in Nature
Verified
Journal Article
Open access
PDF file
MGMuhammet F. Gulen
Muhammet F. Gulen
NSNatasha Samson
Natasha Samson
AKAlexander Keller
Alexander Keller
MSMarius Schwabenland
Marius Schwabenland
CLChong Liu
Chong Liu
AAAndrea Ablasser
Andrea Ablasser
Low-grade inflammation is a hallmark of old age and a central driver of ageing-associated impairment and disease1. Multiple factors can contribute to ageing-associated inflammation2; however, the molecular pathways that transduce aberrant inflammatory signalling and their impact in natural ageing remain unclear. Here we show that the cGAS–STING signalling pathway, which mediates immune sensing of DNA3, is a critical driver of chronic inflammation and functional decline during ageing. Blockade of STING suppresses the inflammatory phenotypes of senescent human cells and tissues, attenuates ageing-related inflammation in multiple peripheral organs and the brain in mice, and leads to an improvement in tissue function. Focusing on the ageing brain, we reveal that activation of STING triggers reactive microglial transcriptional states, neurodegeneration and cognitive decline. Cytosolic DNA released from perturbed mitochondria elicits cGAS activity in old microglia, defining a mechanism by which cGAS–STING signalling is engaged in the ageing brain. Single-nucleus RNA-sequencing analysis of microglia and hippocampi of a cGAS gain-of-function mouse model demonstrates that engagement of cGAS in microglia is sufficient to direct ageing-associated transcriptional microglial states leading to bystander cell inflammation, neurotoxicity and impaired memory capacity. Our findings establish the cGAS–STING pathway as a driver of ageing-related inflammation in peripheral organs and the brain, and reveal blockade of cGAS–STING signalling as a potential strategy to halt neurodegenerative processes during old age.

19 March 2004 in Science
Verified
Journal Article
Closed access
PDF file
PTPriscilla Turelli
Priscilla Turelli
BMBastien Mangeat
Bastien Mangeat
SJStephanie Jost
Stephanie Jost
SVSandrine Vianin
Sandrine Vianin
DTDidier Trono
Didier Trono

4 September 2009 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
BMBastien Mangeat
Bastien Mangeat
GGGustavo Gers-Huber
Gustavo Gers-Huber
MLMartin Lehmann
Martin Lehmann
MZMadeleine Zufferey
Madeleine Zufferey
JLJeremy Luban
Jeremy Luban
VPVincent Piguet
Vincent Piguet
Host cells impose a broad range of obstacles to the replication of retroviruses. Tetherin (also known as CD317, BST-2 or HM1.24) impedes viral release by retaining newly budded HIV-1 virions on the surface of cells. HIV-1 Vpu efficiently counteracts this restriction. Here, we show that HIV-1 Vpu induces the depletion of tetherin from cells. We demonstrate that this phenomenon correlates with the ability of Vpu to counteract the antiviral activity of both overexpressed and interferon-induced endogenous tetherin. In addition, we show that Vpu co-immunoprecipitates with tetherin and β-TrCP in a tri-molecular complex. This interaction leads to Vpu-mediated proteasomal degradation of tetherin in a β-TrCP2-dependent manner. Accordingly, in conditions where Vpu-β-TrCP2-tetherin interplay was not operative, including cells stably knocked down for β-TrCP2 expression or cells expressing a dominant negative form of β-TrCP, the ability of Vpu to antagonize the antiviral activity of tetherin was severely impaired. Nevertheless, tetherin degradation did not account for the totality of Vpu-mediated counteraction against the antiviral factor, as binding of Vpu to tetherin was sufficient for a partial relief of the restriction. Finally, we show that the mechanism used by Vpu to induce tetherin depletion implicates the cellular ER-associated degradation (ERAD) pathway, which mediates the dislocation of ER membrane proteins into the cytosol for subsequent proteasomal degradation. In conclusion, we show that Vpu interacts with tetherin to direct its β-TrCP2-dependent proteasomal degradation, thereby alleviating the blockade to the release of infectious virions. Identification of tetherin binding to Vpu provides a potential novel target for the development of drugs aimed at inhibiting HIV-1 replication. To efficiently replicate in cells, HIV-1 needs to inactivate a number of intracellular host defenses. One such antiviral mechanism is provided by the newly identified tetherin protein. This factor blocks viral production by impeding the release of newly generated HIV-1 particles from the surface of cells. HIV-1 possesses the Vpu protein, which efficiently counteracts this blockade. Here we reveal that HIV-1 Vpu interacts with tetherin and leads to its depletion from cells, possibly through multiple mechanisms, including proteasomal degradation. In order to eliminate tetherin, Vpu hijacks a cellular component, named β-TrCP2, which is normally used by human cells to induce degradation of certain proteins. Identification of tetherin binding to Vpu provides a potential novel target for the development of drugs aimed at inhibiting HIV-1 replication.

19 April 2019 in Genome Biology
Verified
Journal Article
Open access
PDF file
DADaniel Alpern
Daniel Alpern
VGVincent Gardeux
Vincent Gardeux
JRJulie Russeil
Julie Russeil
BMBastien Mangeat
Bastien Mangeat
AMAntonio C. A. Meireles-Filho
Antonio C. A. Meireles-Filho
BDBart Deplancke
Bart Deplancke
Despite its widespread use, RNA-seq is still too laborious and expensive to replace RT-qPCR as the default gene expression analysis method. We present a novel approach, BRB-seq, which uses early multiplexing to produce 3′ cDNA libraries for dozens of samples, requiring just 2 hours of hands-on time. BRB-seq has a comparable performance to the standard TruSeq approach while showing greater tolerance for lower RNA quality and being up to 25 times cheaper. We anticipate that BRB-seq will transform basic laboratory practice given its capacity to generate genome-wide transcriptomic data at a similar cost as profiling four genes using RT-qPCR.

1 April 2004 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
BMBastien Mangeat
Bastien Mangeat
PTPriscilla Turelli
Priscilla Turelli
SLShunyao Liao
Shunyao Liao
DTDidier Trono
Didier Trono
APOBEC3G (also known as CEM15) is an innate intracellular antiretroviral factor that is counteracted by the Vif protein of lentiviruses. While APOBEC3G orthologues from several species are active against a broad range of retroviruses, given Vif proteins have a narrow spectrum of activity. For instance, HIV-1 Vif efficiently blocks APOBEC3G from human but not African green monkey (AGM), whereas the reverse is observed with SIVAGM Vif. Here, we demonstrate that a single amino acid at position 128 of human and AGM APOBEC3G governs the virus-specific sensitivity of these proteins to Vif-mediated inhibition. Furthermore, we show that this phenotype correlates with the ability of Vif to bind APOBEC3G and interfere with its incorporation into virions. These results shed light on an important determinant of the tropism of primate lentiviruses.